mitotane has been researched along with Pseudotumor Cerebri in 1 studies
Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.
Pseudotumor Cerebri: A condition marked by raised intracranial pressure and characterized clinically by HEADACHES; NAUSEA; PAPILLEDEMA, peripheral constriction of the visual fields, transient visual obscurations, and pulsatile TINNITUS. OBESITY is frequently associated with this condition, which primarily affects women between 20 and 44 years of age. Chronic PAPILLEDEMA may lead to optic nerve injury (see OPTIC NERVE DISEASES) and visual loss (see BLINDNESS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marechaud, R | 1 |
| Boissonnot, M | 1 |
| Holderer-Fieuzal, S | 1 |
| Gouet, D | 1 |
| Boissonnot, L | 1 |
1 other study available for mitotane and Pseudotumor Cerebri
| Article | Year |
|---|---|
[Idiopathic intracranial hypertension during treatment of Cushing's disease with mitotane].
Topics: Adult; Cushing Syndrome; Female; Humans; Mitotane; Pseudotumor Cerebri | 1987 |